Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163303 · ClinicalTrials.gov registry record · Phase 4
Smoking Tobacco and Drinking Study
A Phase 4 study of Smoking and Heavy Episodic Drinking, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 179
- Enrollment target
- 1
- Study location
NCT03163303 is a Phase 4 study of Smoking and Heavy Episodic Drinking that has completed, run by University of California, San Francisco. The registered enrollment target is 179 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03163303, a Phase 4 study of Smoking and Heavy Episodic Drinking, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 179 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence abstinence from smoking at 3, 6, and 12 months.
Conditions Studied
Interventions
- DRUG nicotine patch
- BEHAVIORAL Tobacco Status Project Intervention
- BEHAVIORAL Tobacco Status Project + Alcohol Intervention
Study Locations (1)
California
- University of California San Francisco Department of Psychiatry - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03163303
The ClinicalTrials.gov registry entry for NCT03163303 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 179 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (61% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 3 interventions - of which nicotine patch is the first listed.
NCT03163303 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03163303 about?
NCT03163303 is a clinical study titled "Smoking Tobacco and Drinking Study". This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence ab...
What is the current status of trial NCT03163303?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 179 participants. The study started on 2017-12-18. Estimated completion is 2019-06-30.
What conditions does trial NCT03163303 study?
This clinical trial studies the following conditions: Smoking, Heavy Episodic Drinking.
What interventions are being tested in trial NCT03163303?
The interventions under investigation include: nicotine patch (DRUG), Tobacco Status Project Intervention (BEHAVIORAL), Tobacco Status Project + Alcohol Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03163303?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03163303 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Identifying Treatments to Motivate Smokers to Quit
COMPLETED · Phase 4
-
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
COMPLETED · Phase 4
-
Long-term Varenicline Treatment for Smoking Cessation
COMPLETED · Phase 4
-
Bupropion SR Plus Counseling for Smoking Cessation
COMPLETED · Phase 4
-
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.